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IDEA TO WATCHA Niche Mechanism for β-Cell Regeneration in Type 1
DiabetesDavid J. HodsonType 1 diabetes (T1D) occurs when insulin-secreting pancreatic β-
cells are selectivelydestroyedby immuneattack.[1]TreatmentofT1D
therefore requires insulin replacement therapy to enable control
over blood glucose levels. While effective, there are issues with
injecting insulin, including the loss of protective counter-regulatory
responses.Replenishment of endogenousβ-cells therefore remains
adesirablegoal forT1Dtherapy.However,becauseβ-cell turnover in
adults is largely through replication[2] and β-cells are lost during
T1D, other non-β-cell sources need to be identiﬁed.
Suggesting that progenitors might be important during islet
injury, β-cells renew following diphtheria toxin-mediated abla-
tion.[3] Remarkably, these β-cells descend from α- and δ-cells.[3]
Given thatα-cellspersist inT1Dislets, this couldprovide abasis for
the restoration of functional β-cell mass. Whether or not similar
mechanisms inﬂuence β-cell renewal in the absence of manoeu-
vres to induce profound plasticity has been difﬁcult to assess.
In this issue of BioEssays, Huising et al.[4] discuss and expand
on recent ﬁndings suggesting that plasticity is intrinsic to the
unstressed islet. Based on absence of the β-cell maturity marker,
urocortin 3 (Ucn3), recent studies have shown the existence of a
neogenic niche in adult islets.[5] β-cells belonging to the niche
occupy the islet periphery, where α-cells aggregate, and constitute
just 1.5%of the total population. These “virgin” cells are insulinþ,
but are transcriptionally immature and glucose unresponsive.
Notably, virgin β-cells were shown to represent an intermediate
stage in the transdifferentiation of α- to β-cells. These ﬁndings are
importantbecause they suggest thatprogenitor-like cellswithanα-
cell ancestry might give rise to new β-cells.
So how do the authors propose to further test this intriguing
hypothesis? β-cells can be labeled using reporter lines, before
tracking and quantiﬁcation.While identical experiments showedDr. D. J. Hodson
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BioEssays 2018, 40, 1800177 1800177 (1 of 1)that β-cell renewal is through replication,[2] the Cre-driver lines
used display poor recombination efﬁciency, decreasing the
power to detect changes. Lineage tracing can also be deployed to
determine whether virgin β-cells convert into mature β-cells. To
understand the contribution of transdifferentiation to this
process, the number of mature (Ucn3þ) β-cells with an α-cell
lineage label can be quantiﬁed. If the neogenic niche is relevant
for T1D, the authors suggest that β-cells possessing an α-cell
lineage label should accumulate in the face of ongoing immune
destruction in NOD mouse models.
The proposed studies will provide further mechanistic insight
into the role of theneogenic niche inβ-cell regeneration.However,
lineage tracing has drawbacks. In particular, transgenic α-cell
driver lines can possess variable recombination efﬁciency and
leakiness in different labs. Latest generation CRISPR knock-in
animals should help here. It will be interesting to understand how
the islet microenvironment inﬂuences the niche. This could take
the formof experiments in re-aggregated isletswherenormalα-/β-
cell interactions are lost. Whether or not virgin β-cells give rise to
mature β-cells that can proliferate in the face of immune
inﬁltration also needs to be established. Perhaps themost difﬁcult
aspect of studying β-cell regeneration, however, is extending
ﬁndings tohumans.WhileUcn3-negativeβ-cells also exist in islets
fromyoungdonors, their capacity to formnewβ-cells is unknown.
Isolation of these putative virgin β-cells for screening with
compound libraries might help identify lead candidates with
replicative/proliferative potential. Lastly, the extent towhich virgin
β-cells canreplenish theβ-cell complementneeds tobeestablished
to better demonstrate clinical applicability.Conflict of Interest
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